GILD
$GILD
Gilead Sciences, Inc.
Biopharmaceutical company focused on HIV, hepatitis, and oncology.
Healthcare$139.03
+0.04 (+0.03%)
Day Range$137.02 - $139.55
Prev Close$138.99
Analyst Rating
Strong Buy
31 Buy / 8 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Apr 19
Weekly updates
Latest Report
GILD: M&A, Yield and Growth Outlook ($GILD)
Gilead ($GILD) sits at a crossroads as recent asset deals and option flow point to renewed investor optimism. The stock offers income plus upside tied to product lifecycle and M&A execution.
Apr 6, 2026